ERS Genomics & abm enter into CRISPR/Cas9 Licensing Agreement This License allows abm to develop and commercialize products using CRISPR/Cas9 technology. Dublin, Ireland and Vancouver, Canada, 1st June 2023:  ERS Genomics Limited (‘ERS’) is pleased to announce a new license agreement with Applied Biological Materials Inc (‘abm,’). This is a non-exclusive licensing agreement granting abm access to the ERS CRISPR/Cas9 [...]

MUNICH, Germany and TEL AVIV, Israel -- NurExone Biologic Inc. (the "Company" or "NurExone") NRX (FSE: J90), a biopharmaceutical company developing biologically-guided exosome therapy ("ExoTherapy") for patients with traumatic spinal cord injuries, is pleased to announce a pioneering collaboration with the German company, Particle Metrix, a leading provider of particle analysis devices. In connection with [...]

Understanding cellular ultrastructure in 3D context with ZEISS Volutome WHITE PLAINS, N.Y. -- The newly introduced ZEISS Volutome is an in-chamber ultramicrotome for ZEISS field emission scanning electron microscopes (FE-SEM). It is designed to image the ultrastructure of biological, resin-embedded samples in 3D in life sciences. Scanning electron microscopy (SEM) in general can be used to [...]

AMSBIO announce MatriMix – a groundbreaking 3D culture substrate. This pioneering hydrogel sets a new benchmark in the field, containing fully defined components, including medical grade collagens, laminin-511 E8 fragments, and hyaluronic acid. The high lot-to-lot consistency of MatriMix enables researchers to obtain highly reproducible results. MatriMix overcomes the limitations of current 3D substrates, enabling cutting-edge applications such as organoid [...]

Published findings demonstrate PrimateAI-3D's ability to improve genetic risk prediction and drug target discovery using primate DNA and advanced artificial intelligence SAN DIEGO -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the new PrimateAI-3D, an artificial intelligence (AI) algorithm that predicts with unprecedented accuracy disease-causing genetic mutations in [...]

Kieran Murphy and Kugan Sathiyanandarajah become members of the Biotage board of directors   Uppsala, Sweden – Biotage has completed the acquisition of Astrea Bioseparations, a high-growth chromatography solutions provider from Gamma Biosciences, a life sciences tools platform created by KKR. Astrea’s over 150 employees worldwide will join Biotage, and the company’s production sites in Cambridge, [...]

The companies agree to a worldwide Human Platelet Lysate (HPL) Patent License and Assignment Agreement, including redirection of HPL customers from Macopharma to PL BioScience. AACHEN, Germany -- PL BioScience GmbH, a German life science company specializing in the production and development of Human Platelet Lysate (HPL) for cell expansion, today announced a Patent License [...]

Highly multiplexed, patented and patent-pending GT-Plex™ PCR assays for low-level, reliable mutation detection These kits are for Research Use Only (RUO) Not for use in diagnostic purposes FORT COLLINS, Colo. -- GT Molecular, Inc., a company providing ultrasensitive PCR assays for cancer research, pathogen detection, and wastewater-based epidemiology testing is entering the cancer molecular assay [...]

Shimadzu Corporation released the Peakintelligence for GCMS Ver. 2 software for triple quadrupole gas chromatograph mass spectrometers (GC-MS/MS) on June 1. This software makes it possible for anyone to easily analyze data acquired from a GC-MS/MS using Shimadzu’s proprietary artificial intelligence (AI) algorithms. In addition to the Smart Metabolites Database *1, which was introduced in Ver.1 *2 released [...]

RNA fusions can be used as biomarkers to identify cancer sub-types and monitor for residual disease SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and CeGaT GmbH, a global provider of sequencing services for research, clinical studies, and [...]